Ocular Therapeutix (OCUL) PT Lowered to $27 at JMP Securities, Following Clinical Business Update
Tweet Send to a Friend
JMP Securities analyst Jonathan Wolleben lowered the price target on Ocular Therapeutix (NASDAQ: OCUL) to $27.00 (from $34.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
